DOJ cuts deferred prosecution deal with bankrupt pharma
The Department of Justice’s antitrust division has charged Rising Pharmaceuticals with conspiring to fix prices and allocate customers for a generic hypertension drug, but resolved the charge with a deferred prosecution agreement.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10